HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Daniel R Budman Selected Research

LY 293111 (LY293111)

8/2005Phase I and pharmacokinetic study of LY293111, an orally bioavailable LTB4 receptor antagonist, in patients with advanced solid tumors.
10/2004Studies of synergistic and antagonistic combinations of conventional cytotoxic agents with the multiple eicosanoid pathway modulator LY 293111.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Daniel R Budman Research Topics

Disease

27Neoplasms (Cancer)
01/2018 - 01/2002
21Breast Neoplasms (Breast Cancer)
01/2016 - 01/2002
5Leukemia
08/2009 - 02/2002
2Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2018 - 01/2002
2Sarcoma (Soft Tissue Sarcoma)
10/2004 - 04/2002
2Prostatic Neoplasms (Prostate Cancer)
06/2003 - 11/2002
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
05/2016
1Lung Neoplasms (Lung Cancer)
05/2016
1Triple Negative Breast Neoplasms
11/2013
1Acute Promyelocytic Leukemia
06/2013
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
06/2013
1Multiple Myeloma
06/2013
1Autoimmune Diseases (Autoimmune Disease)
06/2013
1Venous Thrombosis (Deep-Vein Thrombosis)
11/2012
1Thrombosis (Thrombus)
11/2012
1Pulmonary Embolism
11/2012
1Venous Thromboembolism
11/2012
1Ovarian Neoplasms (Ovarian Cancer)
12/2011
1Heart Neoplasms
12/2010
1Inflammation (Inflammations)
12/2010
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
04/2010
1Blast Crisis (Blast Phase)
04/2010
1Hypersensitivity (Allergy)
01/2009
1Diarrhea
12/2008

Drug/Important Bio-Agent (IBA)

6Paclitaxel (Taxol)FDA LinkGeneric
01/2013 - 12/2004
5Docetaxel (Taxotere)FDA Link
01/2013 - 07/2002
5Doxorubicin (Adriamycin)FDA LinkGeneric
03/2012 - 02/2002
4Trastuzumab (Herceptin)FDA Link
01/2013 - 01/2006
4GemcitabineFDA Link
03/2012 - 10/2004
4Capecitabine (Xeloda)FDA Link
12/2008 - 10/2002
4Cyclophosphamide (Cytoxan)FDA LinkGeneric
05/2008 - 02/2002
4Fluorouracil (Carac)FDA LinkGeneric
05/2008 - 02/2002
3Hormones (Hormone)IBA
01/2016 - 11/2002
3TamoxifenFDA LinkGeneric
01/2016 - 02/2002
3Antineoplastic Agents (Antineoplastics)IBA
12/2008 - 01/2005
3Cytotoxins (Cytolysins)IBA
07/2007 - 12/2004
3Pharmaceutical PreparationsIBA
12/2004 - 07/2002
2Monoclonal AntibodiesIBA
01/2018 - 09/2007
2ErbB Receptors (EGF Receptor)IBA
11/2013 - 09/2006
2Biological ProductsIBA
01/2013 - 03/2012
2Histone Deacetylase InhibitorsIBA
03/2012 - 12/2011
2PlatinumIBA
12/2011 - 01/2009
2A-Form DNA (A-DNA)IBA
01/2011 - 04/2002
2Biomarkers (Surrogate Marker)IBA
05/2009 - 09/2007
2Cisplatin (Platino)FDA LinkGeneric
01/2009 - 01/2006
2Carboplatin (JM8)FDA LinkGeneric
01/2009 - 01/2006
2FluvastatinFDA Link
07/2007 - 01/2006
2Irinotecan (Camptosar)FDA LinkGeneric
04/2007 - 10/2004
2doxifluridineIBA
09/2006 - 10/2004
2Vinorelbine (Navelbine)FDA LinkGeneric
01/2006 - 11/2002
2LY 293111 (LY293111)IBA
08/2005 - 10/2004
1AntibodiesIBA
01/2018
1Rituximab (Mabthera)FDA Link
01/2018
1AntigensIBA
01/2018
1Neoplasm Antigens (Tumor Antigens)IBA
01/2018
1Immune Checkpoint ProteinsIBA
05/2016
1Immune Checkpoint InhibitorsIBA
05/2016
1LigandsIBA
05/2016
1IntegrinsIBA
11/2013
1Staphylococcal Protein A (Protein A)IBA
11/2013
1ArsenicIBA
06/2013
1Arsenic Trioxide (Trisenox)FDA Link
06/2013
1maytansinolIBA
01/2013
1Alanine (L-Alanine)FDA Link
01/2013
1Ado-Trastuzumab EmtansineIBA
01/2013
1Immunoconjugates (Immunoconjugate)IBA
01/2013
1EstersIBA
01/2013
1Maytansine (Maitansine)IBA
01/2013
1pertuzumabIBA
01/2013
1Factor Xa InhibitorsIBA
11/2012
1Fondaparinux (Arixtra)FDA Link
11/2012
1SurvivinIBA
03/2012
1Drug CombinationsIBA
03/2012
1PanobinostatIBA
12/2011
1Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
01/2011
1Poly(ADP-ribose) Polymerase InhibitorsIBA
01/2011
1Small Interfering RNA (siRNA)IBA
01/2011
1RNA (Ribonucleic Acid)IBA
12/2010
1MicroRNAs (MicroRNA)IBA
12/2010
1Transcription Factors (Transcription Factor)IBA
12/2010
1amonafideIBA
04/2010
1Cytarabine (Cytosar-U)FDA LinkGeneric
04/2010
1Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2009
1BMS 310705IBA
12/2008
1desoxyepothilone B (epothilone D)IBA
12/2008
1taxaneIBA
12/2008
1ixabepilone (BMS 247550)FDA Link
12/2008
1Taxoids (Taxanes)IBA
12/2008
1sagopiloneIBA
12/2008
1epothilone B (EPO906)IBA
12/2008
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
08/2008
1Proteins (Proteins, Gene)FDA Link
09/2007
1SynucleinsIBA
09/2007

Therapy/Procedure

12Therapeutics
01/2018 - 10/2004
6Drug Therapy (Chemotherapy)
08/2009 - 12/2004
3Adjuvant Chemotherapy
08/2009 - 04/2006
2Vena Cava Filters (Inferior Vena Cava Filter)
11/2012 - 05/2009
2Combination Drug Therapy (Combination Chemotherapy)
08/2009 - 07/2002
1Remission Induction
06/2013
1Salvage Therapy
01/2009